Pol F Boudes
CIK 1454771 · Chief Medical Officer · last filed 2025-09-04
Pol F Boudes is a Chief Medical Officer who has filed 24 SEC Form 4 insider transactions across 4 companies since 2009. The most recent filing, for PLX, was dated Sep 4, 2025. Current disclosed insider exposure totals $18.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$18.3K
4
24
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLX | Director | 7,540 | $2.43 | $18.3K | $0 | 4 | 2025-09-04 |
| GALT | Chief Medical Officer | — | $3.13 | — | $0 | 5 | 2024-02-07 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Chief Medical Officer | — | $32.48 | — | $0 | 7 | 2019-01-31 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Chief Medical Officer | — | $14.49 | — | $0 | 7 | 2012-06-06 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-04 | PLX | Grant (A) | +7,500 | $0 | EDGAR |
| 2024-10-04 | GALT | Notice (144) | −453,750 | -$1.23M | EDGAR |
| 2024-02-07 | GALT | Grant (A) | — | $0 | EDGAR |
| 2023-10-03 | PLX | Grant (A) | — | $0 | EDGAR |
| 2023-01-30 | GALT | Grant (A) | — | $0 | EDGAR |
| 2022-09-09 | PLX | Grant (A) | — | $0 | EDGAR |
| 2022-01-25 | GALT | Grant (A) | — | $0 | EDGAR |
| 2021-03-29 | GALT | Grant (A) | — | $0 | EDGAR |
| 2020-03-16 | GALT | Grant (A) | — | $0 | EDGAR |
| 2020-01-22 | PLX | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.